...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Cachexia, Sarcopenia and Muscle >The 6th Cachexia Conference: an introduction to clinical and basic research in an exiting area
【24h】

The 6th Cachexia Conference: an introduction to clinical and basic research in an exiting area

机译：第六届恶病质会议：现有领域的临床和基础研究简介

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

This year, all 155 abstracts submitted for evaluation and accepted for presentation until end of September 2011 are included in this issue of the Journal of Cachexia, Sarcopenia and Muscle (JCSM). Abstracts accepted later will be printed in the first issue of 2012. Also, the number of abstracts has substantially increased since the initial conference (Fig.?1), and as you will see during the conference in Milan, an increased amount of space and time is given to poster discussions.;The first issue of JCSM has been published in September 2010. JCSM is published quarterly as a hard copy journal as well as on an open-access basis without page charges for authors. All submitted articles are undergoing peer review. In April 2011, after appearance of only its third issue, JCSM was accepted for indexing in PubMed?. We are proud to say that all issues of JCSM are included in PubMed? and can be downloaded free of charge from PubMed Central as well as from the journal’s dedicated websites at www.jcsm.info and www.jcsm.springer.de.;Since publication of the first issue of JCSM, three double-blind, randomized, placebo-controlled trials covering different aspects and therapeutic approaches to cachexia, have been included in the journal [1–3]. In addition, the rationale and design of two clinical studies (one a registry and the other a phase II clinical trial) have also been published in JCSM [4, 5]. We invite everyone to follow this example. Please help us to make JCSM the premier journal to read about dedicated treatment and prevention studies in the fields of cachexia and sarcopenia. According to Google Scholar, the total number of citations of all 12 articles published in 2010 alone sums up to 104 [6]. Therefore, authors submitting to JCSM have a high likelihood of broad awareness of their results.;We were horrified when we learned about the tragic events in Fukushima and its surroundings that ultimately forced us to re-schedule our meeting. Our thoughts are with our Japanese colleagues and their families. We also sincerely hope that our next meeting in December 2013 can successfully take place in Kobe/Japan as originally planned for this year.;But now we are in Milan and we want to sincerely thank the local organizers, the society staff and all our supporters in academica and industry for having helped us to make this conference possible. We wish all participants of the 6th Cachexia Conference an interesting and stimulating meeting and hope to meet up during the sessions, the poster discussions, or at one of the evening events. Many of you will be contacted to submit original papers and/or reviews to our journal. Only through the exchange of ideas and scientific research results we can ultimately achieve what this is all about—improve the lives of our patients. Cachexia, sarcopenia, and muscle wasting are big medical needs, and you and your publications are a seminal building stone of future therapeutic successes. Please feel invited to submit your work to JCSM. We promise, we will give it our undivided attention and turn around your manuscripts fast.;This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
机译：今年，所有155篇摘要均已提交评估，并已接受发表，直至2011年9月底，已纳入本期恶病质，肌肉减少症和肌肉杂志（JCSM）。稍后接受的摘要将在2012年第一期出版。此外，自首次会议以来，摘要的数量已大大增加（图1），并且正如您在米兰会议期间所看到的那样，增加了空间和JCSM的第一期已于2010年9月出版。JCSM季刊以纸质期刊的形式以及以开放获取的形式出版，作者无需支付页面使用费。所有提交的文章都在接受同行评审。 2011年4月，JCSM仅出现了第三期，就被PubMed？收录了索引。我们很自豪地说所有JCSM问题都包含在PubMed中？并可以从PubMed Central以及该杂志的专用网站www.jcsm.info和www.jcsm.springer.de免费下载;自JCSM发行第一期以来，已有三本双盲，随机，该杂志涵盖了涵盖恶病质不同方面和治疗方法的安慰剂对照试验[1-3]。此外，JCSM还发表了两项临床研究的原理和设计（一项注册研究，另一项为II期临床试验）[4，5]。我们邀请所有人遵循此示例。请帮助我们使JCSM成为主要期刊，以阅读有关恶病质和肌肉减少症领域的专门治疗和预防研究。根据Google Scholar的统计，仅在2010年发表的所有12篇文章的被引用总数就达到104 [6]。因此，向JCSM提交论文的作者极有可能广泛了解他们的结果。;当我们得知福岛及其周边地区的悲剧性事件最终迫使我们重新安排会议时，我们感到震惊。我们的想法与我们的日本同事及其家人在一起。我们也衷心希望我们的初次会议能按原定计划于2013年12月在日本神户成功举行;但是现在我们在米兰，我们要衷心感谢当地组织者，社会工作人员和所有支持者在学术界和工业界的贡献，帮助我们使这次会议成为可能。我们希望第六届恶病质恶性肿瘤会议的所有参加者都能够参加有趣而刺激的会议，并希望在会议，海报讨论或晚间活动之一中见面。我们会与您中的许多人联系，以向我们的期刊提交原始论文和/或评论。只有通过交流思想和科学研究成果，我们才能最终实现这一切，从而改善患者的生活。恶病质，肌肉减少症和肌肉消瘦是巨大的医疗需求，您和您的出版物是未来治疗成功的重要基础。请感到受邀将您的工作提交给JCSM。我们承诺，我们将全力以赴，并迅速处理您的手稿。;本文是根据知识共享署名非商业使用许可的条款发行的，该许可允许在任何介质中进行任何非商业使用，分发和复制，但要提供原始作者的权利（s）和来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号